Basic Information
VIS ID
TVIS10002730
Fusion event
HBV-chr16 integration
Validated
No
Detection method
HIVID
Data source
Curated
Sample type
Tumor
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Reported year
2016
PubMed ID
27703150
Virus Sequence
Virus name
HBV
Reference genome
AF090842.1;AB033554.1;AB014381.1;M32138.1;AB032431.1;AB036910.1;AB064310;AY090454.1
Host Sequence
Chromosome
chr16
Cytoband
p13.3
Reference genome
GRCh37/hg19
Start
69751/19751 (Hg38)
End
69751/19751 (Hg38)
Location type
Promoter;downstream
Target gene
DDX11L10 ; MIR6859-1 ; MIR6859-2
Nearest miRNA
hsa-mir-6859-4/Upstream/2632; hsa-mir-11401/Downstream/515565;
Nearest TSS
ENST00000527434/Downstream/3159;
Nearest CpG islands
None/Target, None/Upstream, chr16-CpG: 29/Downstream/3092
Upstream sequence
aaccctaatccggaccctgaaccctaacccggaccactgaaccctaacaccgaccctgaaccctaaccccgaccctcaccctgaccctcaccctaccctg
Downstream sequence
accctcaccctgaccctgaccctgaccctcaccctgaccctgactctgaccctgaccctgaccctgactctaaccctaaccctgaccctgaccctgaccc
Reference
Zhao, L. H., et al.Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma. Nat Commun ,2016,7: 12992.
Curate